Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 11;4(2):e365.
doi: 10.1002/ski2.365. eCollection 2024 Apr.

Dupilumab as an innovative therapy for symptomatic management of chemotherapy-induced pruritus: A case series

Nupur Singh  1 , Anna Conner  1 , Zachary Nahmias  2
Affiliations

Dupilumab as an innovative therapy for symptomatic management of chemotherapy-induced pruritus: A case series

Nupur Singh et al. Skin Health Dis. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Similar articles

See all similar articles

References

    1. Gooderham MJ, Hong HC, Eshtiaghi P, Papp KA. Dupilumab: a review of its use in the treatment of atopic dermatitis. J Am Acad Dermatol. 2018;78(3 Suppl 1):S28–S36. 10.1016/j.jaad.2017.12.022 - DOI - PubMed
    1. Shin YH, Hwang J, Kwon R, Lee SW, Kim MS, Shin JI, et al. Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: a systematic analysis for the global burden of disease study 2019. Allergy. 2023;78(8):2232–2254. 10.1111/all.15807 - DOI - PMC - PubMed
    1. Gael M, Adam T, Mariano‐Bourin M, Bursztejn AC. Efficacy of dupilumab in chronic prurigo and chronic idiopathic pruritus: a systematic review of current evidence and analysis of response predictors. J Eur Acad Dermatol Venereol. 2022;36(9):1541–1551. 10.1111/jdv.18221 - DOI - PubMed
    1. Kychygina A, Cassagne M, Tauber M, Galiacy S, Paul C, Fournié P, et al. Dupilumab‐associated adverse events during treatment of allergic diseases. Clin Rev Allergy Immunol. 2022;62(3):519–533. 10.1007/s12016-022-08934-0 - DOI - PubMed
    1. Ensslin CJ, Rosen AC, Wu S, Lacouture ME. Pruritus in patients treated with targeted cancer therapies: systematic review and meta‐analysis. J Am Acad Dermatol. 2013;69(5):708–720. 10.1016/j.jaad.2013.06.038 - DOI - PMC - PubMed

LinkOut - more resources